Who has invested in BioShin?

OrbiMed are named among the investors backing BioShin.

BioShin Funding: $60M Raised, Series A (2021)

BioShin funding overview

BioShin is based in Shanghai, China. BioShin has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2021. The round record for BioShin runs through 2021; nothing later has been disclosed. Investors on record include OrbiMed.

BioShin at a glance

Total raised: $60M
Latest round: Series A
Latest round date: April 2021
Headquarters: Shanghai, China
Notable investors: OrbiMed

Frequently asked about BioShin funding

How much has BioShin raised?: BioShin has raised $60M in total disclosed funding across the rounds on record.
Who has invested in BioShin?: OrbiMed are named among the investors backing BioShin.
What was the latest BioShin funding round?: The most recent disclosed round is a Series A, announced in April 2021.
Where is BioShin based?: BioShin is based in Shanghai, China.
When did BioShin last raise?: The last disclosed BioShin round closed in April 2021 at Series A.

We update the BioShin record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Shanghai and their backers are listed below.

BioShin Funding: $60M Raised, Series A (2021)

BioShin funding overview

BioShin at a glance

Frequently asked about BioShin funding

Companies related to BioShin (36)

Browse related funding lists (5)